Yifeng Pharmacy Chain Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Yifeng Pharmacy Chain Co., Ltd. carries a market capitalization of 24.45B, placing it among publicly traded companies globally. Its enterprise value stands at 27.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 24.45B |
| Enterprise Value | 27.61B |
Share Statistics
Yifeng Pharmacy Chain Co., Ltd. currently has 1.21B shares outstanding.
| Shares Outstanding | 1.21B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Yifeng Pharmacy Chain Co., Ltd. trades at a trailing price-to-earnings ratio of 18.45. The price-to-sales ratio is 1.24, and the price-to-book ratio stands at 4.26.
| PE Ratio | 18.45 |
| PS Ratio | 1.24 |
| PB Ratio | 4.26 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 56.94 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Yifeng Pharmacy Chain Co., Ltd. trades at an EV/EBITDA multiple of 11.36 and an EV/FCF ratio of 39.60. The EV/Sales ratio of 1.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.15 |
| EV / EBITDA | 11.36 |
| EV / EBIT | 11.36 |
| EV / FCF | 39.60 |
Financial Position
Yifeng Pharmacy Chain Co., Ltd. maintains a current ratio of 1.38, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.24, indicating elevated leverage, while an interest coverage ratio of 11.37 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.38 |
| Quick Ratio | 0.73 |
| Debt / Equity | 41.24 |
| Debt / EBITDA | 2.02 |
| Interest Coverage | 11.37 |
Financial Efficiency
Yifeng Pharmacy Chain Co., Ltd. posts a return on equity of 24.31 and a return on invested capital of 10.79.
| Return on Equity (ROE) | 24.31 |
| Return on Assets (ROA) | 6.11 |
| Return on Invested Capital (ROIC) | 10.79 |
| Return on Capital Employed (ROCE) | 13.04 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.58 |
Taxes
Over the trailing twelve months, Yifeng Pharmacy Chain Co., Ltd. has paid 576.04M in income taxes, reflecting an effective tax rate of 24.89.
| Income Tax | 576.04M |
| Effective Tax Rate | 24.89 |
Stock Price Statistics
Yifeng Pharmacy Chain Co., Ltd.'s stock has declined approximately -18.86565% over the past 52 weeks. The 50-day moving average sits at 21.16, while the 200-day moving average is 23.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.86565% |
| 50-Day Moving Average | 21.16 |
| 200-Day Moving Average | 23.05 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Yifeng Pharmacy Chain Co., Ltd. generated 24.02B in revenue and converted that into 1.61B in net income, yielding earnings per share of 1.39. EBITDA reached 2.43B, while operating income came in at 2.43B.
| Revenue | 24.02B |
| Gross Profit | 9.69B |
| Operating Income | 2.43B |
| Pretax Income | 2.31B |
| Net Income | 1.61B |
| EBITDA | 2.43B |
| EBIT | 2.43B |
| Earnings Per Share (EPS) | 1.39 |
Balance Sheet
Yifeng Pharmacy Chain Co., Ltd. holds 7.75B in cash and equivalents against 4.90B in total debt, resulting in a net debt position of -1.65B. Total book value stands at 6.97B, with working capital of 4.06B providing operational flexibility.
| Cash & Cash Equivalents | 7.75B |
| Total Debt | 4.90B |
| Net Debt | -1.65B |
| Equity (Book Value) | 6.97B |
| Book Value Per Share | 5.74 |
| Working Capital | 4.06B |
Cash Flow
After subtracting -536.58M in capital expenditures, free cash flow totaled -536.58M - equivalent to -0.44 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -536.58M |
| Free Cash Flow | -536.58M |
| FCF Per Share | -0.44 |
Margins
Yifeng Pharmacy Chain Co., Ltd. operates with a gross margin of 40.32, reflecting its pricing power and cost economics. The operating margin of 10.12 and net profit margin of 6.71 provide insight into operational efficiency.
| Gross Margin | 40.32 |
| Operating Margin | 10.12 |
| Pretax Margin | 9.64 |
| Profit Margin | 6.71 |
| EBITDA Margin | 10.12 |
Dividends & Yields
The company's payout ratio of 55.11 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.85 |
| Dividend Yield | N/A |
| Payout Ratio | 55.11 |
| Shareholder Yield | 9.38 |
| FCF Yield | 1.76 |
Stock Splits
Yifeng Pharmacy Chain Co., Ltd.'s most recent stock split took place on June 7, 2024 with a 5:6 split ratio.
| Last Split Date | 6/7/2024 |
| Split Ratio | 5:6 |
Scores
Yifeng Pharmacy Chain Co., Ltd. posts an Altman Z-Score of 3.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.37 |